The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.

The glucagon-like peptide-1 (GLP-1) receptor agonist gained accelerated approval for patients with MASH and moderate to ...

After a more than decadelong process to bring the experimental drug elamipretide to market, the treatment’s approval has ...

Sublingual cyclobenzaprine (Tonmya), a nonopioid treatment for adults with fibromyalgia, targets nonrestorative sleep, a root ...

US regulators sent seemingly mixed messages this month about the outlook for animal-derived, or desiccated, thyroid medicines ...

Robert F. Kennedy Jr. has said the CDC's vaccine advisory board was rife with conflicts of interest. A new analysis shows ...

A new study shows access to birth control has increased following the FDA's approval of an over-the-counter birth control pill. In the two years since the pill went on the market, there's a 31.8% ...

The biotech, which cut jobs following the rejection in May of its Barth syndrome therapy, claimed it has addressed the agency ...

After an FDA rejection in May, Stealth BioTherapeutics has resubmitted a new drug application for its investigational ...

The FDA’s recent issue of five warning letters to brands illegally marketing whipped, mousse and foam sunscreen products ...

When the Food and Drug Administration needs outside guidance, it normally turns to a trusted source: a large roster of expert ...

Dr. David Kessler, former FDA commissioner, has formally petitioned RFK Jr. to remove key ingredients in ultra-processed ...